• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受腹腔静脉分流术的患者中研究人类肿瘤转移的机制。

Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

作者信息

Tarin D, Price J E, Kettlewell M G, Souter R G, Vass A C, Crossley B

出版信息

Cancer Res. 1984 Aug;44(8):3584-92.

PMID:6744281
Abstract

The technique of peritoneovenous shunting for the alleviation of abdominal pain and distension in malignant ascites due to inoperable cancer, returns the fluid to the circulation via a one-way, valved, anastomosis between the peritoneum and the jugular vein. Surprisingly, although the patients treated with this technique receive direct infusions of malignant tumor cells into the blood, this study of 29 patients, 15 of whom came to autopsy, shows that they did not all develop metastases, some being completely free of such lesions despite long survival. Even when metastases do form, they are small and clinically asymptomatic, and the technique is therefore not hazardous. In some patients, inert tumor cells identifiable by natural markers were recognized in the tissues, but no growing metastases were observed. In others, the distribution of secondary deposits was unexpected in that metastases did not form in the organ containing the first capillary bed encountered, although hematogenous metastases had formed in other organs. Despite the fact that various factors such as (a) the small numbers of patients treated with the technique; (b) the sensitive nature of studies on terminally ill patients; and (c) the absence of consistency in the sample population with regard to factors such as length of survival and site of neoplasm, combine to reduce the number of suitable cases for study, the approach has unrivaled power and interest for those seeking to understand mechanisms underlying tumor metastasis in humans.

摘要

腹膜静脉分流术用于缓解因无法手术切除的癌症导致的恶性腹水引起的腹痛和腹胀,该技术通过腹膜与颈静脉之间的单向、带瓣膜的吻合将液体回输至循环系统。令人惊讶的是,尽管接受该技术治疗的患者会直接将恶性肿瘤细胞输入血液,但这项对29例患者(其中15例进行了尸检)的研究表明,并非所有患者都会发生转移,一些患者尽管存活时间长,但完全没有此类病变。即使确实形成了转移灶,它们也很小且临床上无症状,因此该技术并无危险。在一些患者的组织中可识别出由天然标记物标记的惰性肿瘤细胞,但未观察到转移性肿瘤生长。在其他患者中,继发性沉积物的分布出乎意料,因为尽管在其他器官中已形成血行转移,但在遇到的第一个毛细血管床所在的器官中并未形成转移灶。尽管存在多种因素,如(a)接受该技术治疗的患者数量较少;(b)对晚期患者进行研究的敏感性;以及(c)样本人群在生存时间和肿瘤部位等因素方面缺乏一致性,这些因素共同导致适合研究的病例数量减少,但对于那些试图了解人类肿瘤转移潜在机制的人来说,这种方法具有无与伦比的价值和吸引力。

相似文献

1
Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.在接受腹腔静脉分流术的患者中研究人类肿瘤转移的机制。
Cancer Res. 1984 Aug;44(8):3584-92.
2
Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneo-venous shunting. A clinico-pathological report.经腹腔-静脉分流术长期治疗恶性腹水期间无转移后遗症。一份临床病理报告。
Invasion Metastasis. 1984;4(1):1-12.
3
Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts.对接受腹腔静脉分流术治疗的患者进行的人体转移瘤临床病理观察。
Br Med J (Clin Res Ed). 1984 Mar 10;288(6419):749-51. doi: 10.1136/bmj.288.6419.749.
4
"Just Another Statistic".“只是又一个统计数字”
Oncologist. 1998;3(3):III-IV.
5
Patterns of metastases in adenocarcinomas of man. An autopsy study of 4,728 cases.人类腺癌转移模式。对4728例病例的尸检研究。
J Med. 1975;6(1):1-14.
6
[Risk of metastases with a peritoneo-caval shunt for malignant ascites].
Pathologe. 1986 Jul;7(4):213-5.
7
Modeling growth kinetics and statistical distribution of oligometastases.寡转移瘤生长动力学和统计分布建模。
Semin Radiat Oncol. 2006 Apr;16(2):111-9. doi: 10.1016/j.semradonc.2005.12.006.
8
Peritoneovenous shunting for malignant ascites.用于恶性腹水的腹腔静脉分流术。
N Z Med J. 1997 Feb 14;110(1037):33-5.
9
Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.结直肠癌肺转移切除术后生存的免疫组化预后标志物的鉴定
Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.
10
[Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].[丹佛腹腔静脉分流术的经皮植入:介入放射科医生的新机遇]
Radiol Med. 2001 Sep;102(3):154-8.

引用本文的文献

1
CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo.钙调神经磷酸酶激酶β(CAMKKβ)在体外和体内均支持上皮性卵巢癌的生长和存活。
Sci Rep. 2025 Jul 17;15(1):25913. doi: 10.1038/s41598-025-11584-9.
2
Liver Metastasis in Cancer: Molecular Mechanisms and Management.癌症中的肝转移:分子机制与治疗
MedComm (2020). 2025 Feb 27;6(3):e70119. doi: 10.1002/mco2.70119. eCollection 2025 Mar.
3
Role of myeloid-derived suppressor cells in tumor recurrence.髓源性抑制细胞在肿瘤复发中的作用。
Cancer Metastasis Rev. 2023 Mar;42(1):113-142. doi: 10.1007/s10555-023-10079-1. Epub 2023 Jan 14.
4
The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination.循环肿瘤细胞在卵巢癌播散中的作用
Cancers (Basel). 2022 Dec 7;14(24):6030. doi: 10.3390/cancers14246030.
5
Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative.血行转移与肿瘤休眠:是概念还是教条?以血管共选择与嗜血管性血管外游走转移的连续过程作为一种替代观点。
Front Oncol. 2022 Oct 11;12:996411. doi: 10.3389/fonc.2022.996411. eCollection 2022.
6
Current methodologies to detect circulating tumor cells: a focus on ovarian cancer.检测循环肿瘤细胞的当前方法:聚焦于卵巢癌
Am J Cancer Res. 2021 Sep 15;11(9):4111-4126. eCollection 2021.
7
Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.鉴定乳腺癌患者中与乳腺癌脑转移相关的潜在基因。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20211615.
8
Myeloid derived suppressor cells and the release of micro-metastases from dormancy.髓源性抑制细胞与休眠中小转移灶的释放。
Clin Exp Metastasis. 2021 Jun;38(3):279-293. doi: 10.1007/s10585-021-10098-8. Epub 2021 May 20.
9
Humanized anti-DEspR IgG4 antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis rat model.人源化抗 DEspR IgG4 抗体可增加胰腺癌干细胞异种移植腹膜癌模型的总生存期。
BMC Cancer. 2021 Apr 14;21(1):407. doi: 10.1186/s12885-021-08107-w.
10
Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma.肾细胞癌胰腺转移中的肿瘤演变及种子与土壤机制
Cancers (Basel). 2021 Mar 16;13(6):1342. doi: 10.3390/cancers13061342.